EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (5 weeks ago)
Save the date! June 29 at 16 CEST #SaferWorldbyDesign webinar with @MultiCASEInc Title: Use of in silico methods… https://t.co/lr1AsHxSHs
Edelweiss Connect (5 weeks ago)
The first of these new additions is the HepaRG™ Gene Expression Tool which supports users querying gene expression… https://t.co/ydsXlaV6JD
Edelweiss Connect (5 weeks ago)
Provision of HepaRG™ on SaferWorldbyDesign @wepredic/@Biopredic_Intl adding #hepaRG to the #SaferWorldbyDesign pl… https://t.co/ftFGWQ697r
Edelweiss Connect (5 weeks ago)
Join us and #SaferWorldbyDesign partner @Biobide_ for a webinar and discussion Tuesday, June 22 at 16 CEST Teratog… https://t.co/YF8BUygT2E
Edelweiss Connect (5 weeks ago)
RT @Biobide_: Today is the #InternationalALS/MNDAllianceDay! A day of world recognition of ALS/MND, a disease that affects people in every…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA